Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer

张飞; 王瑧; 张萍; 张波; 杨文涛; 李影奕

doi:10.3969/j.issn.1007-3969.2013.05.001

您当前的位置：

首页 >

文章列表页 >

Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer

更新时间：2025-12-31

- Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer
- China Oncology Vol. 23, Issue 5, Pages: 321-327(2013)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院肿瘤研究所，复旦大学上海医学院肿瘤学系,上海
  2. 复旦大学附属肿瘤医院胰腺肝胆外科，复旦大学上海医学院肿瘤学系,上海
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2013.05.001
  CLC：
- Published Online：19 November 2014，
  
  Published：2013
- 稿件说明：
移动端阅览
张飞,王瑧,张萍,张波,杨文涛,李影奕. 异常高表达TCTP通过上调Bcl-xL抑制胰腺癌细胞的细胞凋亡[J]. 中国癌症杂志, 2013, 23(5): 321-327.

张飞, 王瑧, 张萍, et al. Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer[J]. China Oncology, 2013, 23(5): 321-327.
张飞,王瑧,张萍,张波,杨文涛,李影奕. 异常高表达TCTP通过上调Bcl-xL抑制胰腺癌细胞的细胞凋亡[J]. 中国癌症杂志, 2013, 23(5): 321-327. DOI： 10.3969/j.issn.1007-3969.2013.05.001.

张飞, 王瑧, 张萍, et al. Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer[J]. China Oncology, 2013, 23(5): 321-327. DOI： 10.3969/j.issn.1007-3969.2013.05.001.

摘要

背景与目的：胰腺癌是一种常见的恶性肿瘤，病死率高，5年生存率5%，目前尚无很好的治疗方法。翻译控制肿瘤蛋白(translationally controlled tumor protein，TCTP)是一个生长相关的蛋白质，有促进肿瘤生长，抗细胞凋亡的作用，目前有研究显示TCTP在肝癌、结直肠癌中异常高表达，但其在胰腺癌中的相关研究报道较少。本研究通过对TCTP在胰腺癌细胞中的表达及其生物学作用机制分析，致力于寻找新的肿瘤分子靶点，为胰腺癌的靶向治疗提供依据。方法：采用免疫组织化学方法检测胰腺癌组织中TCTP表达情况；RT-PCR检测胰腺癌细胞株中TCTP的mRNA表达，Western blot方法检测胰腺癌细胞株中TCTP和Bcl-xL蛋白表达水平；免疫荧光染色方法检测TCTP在胰腺癌细胞中的定位；小分子RNA干扰技术沉默胰腺癌细胞中TCTP表达后，利用CCK-8试剂盒检测细胞增殖，流式细胞仪检测胰腺癌细胞的细胞周期和细胞凋亡等生物学指标。结果：与正常胰腺组织相比，胰腺癌组织中TCTP异常高表达，并且主要位于胰腺癌细胞的细胞质中；不同胰腺癌细胞株中TCTP也呈高表达；siRNA沉默胰腺癌细胞中的TCTP，显著抑制细胞的增殖速度和细胞周期进程，促进细胞的凋亡；在胰腺癌细胞中Bcl-xL表达与TCTP表达呈正相关，沉默TCTP可以下调Bcl-xL的蛋白表达。结论：异常高表达TCTP，通过上调Bcl-xL抑制细胞凋亡，从而促进胰腺癌的发生和发展。

Abstract

Background and purpose: Translationally controlled tumor protein (TCTP) is a growth-related protein

and involves in promoting cell proliferation and inhibiting cell apoptosis. A lot of evidence shows there is an overexpression of TCTP in liver cancer

colon cancer and other gastrointestinal tumors. However there is no any evidence about TCTP in pancreatic cancer. The present study aimed to investigate the role and mechanism of TCTP in pancreatic carcinogenesis to find new molecular targets and to provide a basis for targeted therapy of pancreatic cancer. Methods: Immunohistochemistry

Western immunoblot analysis

RT-PCR

immunofluorescence analysis

siRNA transfection

cell counting kit 8 (CCK-8) assays

cell cycle and cell apoptosis analysis were used. Results: TCTP was overexpressed in pancreatic cancer tissues and cancer cells. Moreover

silencing TCTP expression by siRNA arrested cell cycle progression

promoted cell apoptosis and eventually inhibited cell proliferation. Furthermore

Bcl-xL protein expression was positively correlatived with TCTP expression in pancreatic cancer cells

and silencing TCTP downregulated Bcl-xL expression. Conclusion: TCTP is overexpressed in human pancreatic cancer

which upregulates Bcl- xL to inhibit cell apoptosis

and eventually promotes pancreatic carcinogenesis.

关键词

Keywords

references

Views

1815

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A research on the mechanism of SERPINA3 promoting malignant progression and gemcitabine resistance of pancreatic cancer by inhibiting ferroptosis

Effect of liposome binding antisense oligonucleotide BP1003 on albumin-bound paclitaxel sensitivity in pancreatic cancer cells by inhibiting STAT3

New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer

Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling

Related Author

Yuan HE

Juncheng GUO

Zhibin YE

Xiaohu WANG

Haonan LI

Jingbiao HUANG

Hua FU

Guochao ZHOU

Related Institution

Department of Gastrointestial Surgery, Hebei General Hospital

The First Clinical College of Changzhi Medical College

Department of Gastrointestial Surgery, Heping Hospital Affiliated to Changzhi Medical College

Department of Hepatology and Gallbladder, Xiangxi Autonomous Prefecture People’s Hospital, Xiangxi

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Pancreatic Cancer Institute, Fudan University

AI问答

⁰